Last checked at 21 Dec 2010 12:19
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters.
1. | Name of the issuer PHYTOPHARM PLC | 2. | State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006). (III) (iii) BOTH (i) AND (ii) |
3. | Name of person discharging managerial responsibilities/director MR ROGER HICKLING, RESEARCH AND DEVELOPMENT DIRECTOR
| 4. | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person AS 3 ABOVE |
5. | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial interest 1 AS 3 ABOVE | 6. | Description of shares (including class), debentures or derivatives or financial instruments relating to shares OPTIONS OVER ORDINARY SHARES OF 1 PENCE EACH |
7. | Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
| 8. | State the nature of the transaction
|
9. | Number of shares, debentures or financial instruments relating to shares acquired
| 10. | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
|
11. | Number of shares, debentures or financial instruments relating to shares disposed | 12. | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
|
13. | Price per share or value of transaction
| 14. | Date and place of transaction
|
15. | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) | 16. | Date issuer informed of transaction
|
If a person discharging managerial responsibilities has been granted options by the issuer
complete the following boxes
17. | Date of grant 17 DECEMBER 2010
| 18. | Period during which or date on which exercisable THESE OPTIONS SHALL BE EXERCISEABLE FROM THE THIRD ANNIVERSARY OF GRANT FOR A PERIOD OF SEVEN YEARS
|
19. | Total amount paid (if any) for grant of the option NIL | 20. | Description of shares or debentures involved (class and number) 512,305 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES
|
21. | Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise 7.35 PENCE PER SHARE
| 22. | Total number of shares or debentures over which 2,245,692 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES |
23. | Any additional information
| 24. | Name of contact and telephone number for queries ZOE MCGOWANCOMPANY SECRETARY 01480 437697 |
Name of authorised official of issuer responsible for making notification ZOE MCGOWAN, COMPANY SECRETARY Date of notification 21 DECEMBER 2010
|
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) | An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. |
(2) | An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. |
(3) | An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. |
(4) | An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. |